M. Sullivan

发表

Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

D S Lawrence, S. Almo, D. Lawrence, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of the human interleukin‐5 gene promoter: involvement of octamer binding sites in the gene promoter activity

M. Sullivan, V. Gruart-Gouilleux, P. Engels, 1995, European journal of immunology.

Genomic organisation of the human cyclic AMP-specific phosphodiesterase PDE4C gene and its chromosomal localisation to 19p13.1, between RAB3A and JUND.

A. Olsen, M. Houslay, M. Sullivan, 1999, Cellular signalling.

Full and Partial Agonists of Muscarinic M3 Receptors Reveal Single and Oscillatory Ca2+ Responses by β2-Adrenoceptors

A. Tobin, G. Willars, M. Sullivan, 2009, Journal of Pharmacology and Experimental Therapeutics.

Identification and Characterization of PDE4A11, a Novel, Widely Expressed Long Isoform Encoded by the Human PDE4A cAMP Phosphodiesterase Gene

Douglas J. MacMaster, Richard Graham Knowles, M. Houslay, 2005, Molecular Pharmacology.

Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.

A. Olsen, L. Gordon, M. Houslay, 1998, The Biochemical journal.

Down-regulation of protein kinase C in rat glioma C6 cells: effects on the beta-adrenergic receptor-coupled adenylate cyclase.

P. Fishman, M. Sullivan, J. Patel, 1987, Biochemical and biophysical research communications.

Molecular cloning of a novel splice variant of human type IVA (PDE-IVA) cyclic AMP phosphodiesterase and localization of the gene to the p13.2-q12 region of human chromosome 19

M. Houslay, M. Sullivan, Y. M. Horton, 1995 .

Molecular cloning and functional expression in yeast of a human cAMP‐specific phosphodiesterase subtype (PDE IV‐C)

H. Lübbert, M. Sullivan, P. Engels, 1995, FEBS letters.

Molecular cloning and expression, in both COS-1 cells and S. cerevisiae, of a human cytosolic type-IVA, cyclic AMP specific phosphodiesterase (hPDE-IVA-h6.1).

M. Houslay, M. Egerton, M. Sullivan, 1994, Cellular signalling.

The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions.

M. Houslay, G. Bolger, M D Houslay, 1998, Advances in pharmacology.

Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene.

G. Baillie, M. Houslay, D. Adams, 2004, The Biochemical journal.

Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10.

M. Houslay, G. Rena, E. Huston, 2001, Molecular pharmacology.

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

Bin Zhang, Michael Sullivan, Sasha Tkachev, 2011, Nucleic Acids Res..

Desensitization of the beta-adrenergic receptor-coupled adenylate cyclase in cultured mammalian cells. Receptor sequestration versus receptor function.

S. Kassis, P. Fishman, M. Sullivan, 1986, The Journal of biological chemistry.

Desensitization of the mammalian beta-adrenergic receptor: analysis of receptor redistribution on nonlinear sucrose gradients.

S. Kassis, M. Sullivan, 1986, Journal of cyclic nucleotide and protein phosphorylation research.

D1 Dopamine Receptors Can Interact with Both Stimulatory and Inhibitory Guanine Nucleotide Binding Proteins

T. Kohout, A. Sidhu, P. Fishman, 1991, Journal of neurochemistry.

The Human Cyclic AMP-specific Phosphodiesterase PDE-46 (HSPDE4A4B) Expressed in Transfected COS7 Cells Occurs as Both Particulate and Cytosolic Species That Exhibit Distinct Kinetics of Inhibition by the Antidepressant Rolipram*

M. Houslay, E. Huston, G. Bolger, 1996, The Journal of Biological Chemistry.

Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.

M. Houslay, G. Rena, S. Mackenzie, 1997, Biochemical Society transactions.

Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast.

M. Houslay, M. Sullivan, M. Wilson, 1994, The Biochemical journal.

Modulation of the beta-adrenergic receptor-coupled adenylate cyclase by chemical inducers of differentiation: effects on beta receptors and the inhibitory regulatory protein Gi.

S. Kassis, P. Fishman, M. Sullivan, 1988, Journal of receptor research.

Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.

M. Houslay, G. Rena, S. Erdogan, 1997, The Biochemical journal.